Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 10, 2026.
medtronic-illumisite is a company within the Medical Devices category. The ILLUMISITE™ platform is Medtronic's leading electromagnetic lung navigation system designed to correct for CT-to-body divergence with real-time visualization during lung biopsy procedures. It enhances image clarity, adjusts to dynamic lung environments, and is compatible with digital fluoroscopes, providing continuous guidance for accurate nodule navigation and sampling.
medtronic-illumisite was founded in Not specified for the product; Medtronic was founded in 1949. and is headquartered in Minneapolis, Minnesota (for parent company Medtronic)..
medtronic-illumisite is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for medtronic-illumisite is Strong.
AI models classify medtronic-illumisite as a Incumbent. AI names brand first.
medtronic-illumisite appeared in 5 of 5 sampled buyer-intent queries (100%). Discoverability for specific product names and key features like 'CT-to-body divergence correction' is expected to be high due to direct keyword usage. Broader, more general queries about lung health or cancer diagnosis might initially lead to Medtronic's overarching brand presence before specific product pages.
The ILLUMISITE™ platform is perceived as an advanced, accurate, and essential tool for lung nodule biopsy, particularly effective in dynamic lung environments. It aims to improve diagnostic accuracy, operational efficiency, and overall lung cancer care through real-time guidance and integrated technology. Key gap: None. The brand's messaging is clear and consistent across all highlighted features and benefits.
Of 5 key facts verified about medtronic-illumisite, 5 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The content is promotional and does not discuss potential limitations, costs, or competitive disadvantages. Clinical evidence cited references single-center studies, which might be a perceived vulnerability for broader applicability without larger multi-center trials.
Buyers turn to medtronic-illumisite for How to accurately biopsy lung nodules?, Challenges of lung motion during biopsy, Improving lung cancer diagnosis accuracy, among 5 documented problem areas.
Buyers evaluating medtronic-illumisite typically ask AI models about "Fluoroscopic navigation system for lung biopsy", "Real-time guidance for lung nodule procedures", "Integrated lung biopsy platform", and 2 similar queries.
Buyers commonly compare medtronic-illumisite with ILLUMISITE platform reviews, Accuracy of lung navigation systems, Benefits of real-time CT-to-body divergence correction, among 5 documented comparison brands.
medtronic-illumisite's core products are ILLUMISITE™ fluoroscopic navigation platform; associated biopsy tools including Sensing catheters, Arcpoint™ pulmonary needle, GenCut™ core biopsy system, SuperLock™ nitinol coil fiducial markers; and the LungGPS™ patient management platform..
medtronic-illumisite uses Not explicitly stated, but typical for medical devices: direct sales, potentially lease agreements, and sales of consumables/disposable tools..
medtronic-illumisite serves Healthcare providers (pulmonologists, thoracic surgeons, interventional radiologists), hospitals, and medical institutions focused on lung cancer diagnosis and interventional pulmonology..
medtronic-illumisite Real-time correction for CT-to-body divergence in dynamic lung environments, continuous guidance for accurate nodule navigation across multiple tool uses, compatibility with digital fluoroscopes, and an integrated suite of diagnostic and patient management tools.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Incumbent
Official website: https://medtronicsolutions.com/
Last analyzed: August 10, 2026
Founded: Not specified for the product; Medtronic was founded in 1949. (source: official website)
Headquarters: Minneapolis, Minnesota (Parent company Medtronic) (source: official website)
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile